OpenEvidence says nearly two‑thirds of ~1 M US physicians use its AI search engine, targeting $400‑$500 M ad revenue by 2026
| Source: Techmeme | Original article
OpenEvidence reports that nearly two‑thirds of roughly one million U.S. physicians use its AI search engine, and a source projects $400‑$500 million in ad revenue by 2026.
OpenEvidence, a Miami‑based startup, says its AI‑driven medical search engine is now used by almost two‑thirds of the roughly one million physicians practising in the United States. The claim, made in an interview with the Financial Times, marks a rapid expansion of the tool that blends clinical queries with advertising‑supported results.
The platform’s growth is translating into a sizable revenue outlook. A source close to the company told the newspaper that the ad‑powered service is on track to generate between $400 million and $500 million in advertising revenue in 2026. The same source noted that the company’s valuation has risen to about $15 billion as hospitals and clinicians increasingly turn to AI to aid diagnosis and treatment decisions.
The figures matter because they signal a shift in how clinicians access medical information. By embedding ads within search results, OpenEvidence is monetising a workflow that traditionally relied on subscription databases or free public resources. Critics argue that the model could blur the line between unbiased clinical evidence and commercial influence, raising questions about patient safety and the integrity of decision‑making.
What to watch next is how regulators and professional bodies respond to the growing reliance on ad‑supported AI tools in clinical settings. Attention will also focus on OpenEvidence’s ability to sustain user growth while navigating scrutiny over the transparency of its advertising algorithm. The company’s upcoming earnings reports and any policy proposals concerning AI‑mediated medical advice will likely shape the broader debate on AI’s role in healthcare.
Sources
Back to AIPULSEN